Skip to content

Genetic Analysis of Children With Cyclic Vomiting Syndrome (CVS) and Migraines

Genetic Analysis of Children With Cyclic Vomiting Syndrome and Migraines

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00727974
Enrollment
586
Registered
2008-08-05
Start date
2008-03-05
Completion date
2013-06-12
Last updated
2019-12-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Migraines, Vomiting

Keywords

Genome Wide Scan (GWS), Mitochondrial scan, Family trios

Brief summary

The purpose of this study is to determine if there are genetic variations that can explain a genetic basis for cyclic vomiting syndrome (CVS).

Detailed description

The purpose of this study is to determine if there are genetic variations that can explain a genetic basis for cyclic vomiting syndrome (CVS), various phenotypes of CVS (e.g. menstrual, Sato, calendar-tied) and migraine headaches (e.g. with aura, without aura, hemiplegic migraine). This information will allow physicians to improve care for patients who have been diagnosed with this disease and to provide their parents with more complete information regarding the cause of this disease. This research is being done because many unanswered questions remain regarding children with CVS.

Interventions

None listed

Sponsors

Children's Hospital and Health System Foundation, Wisconsin
CollaboratorOTHER
Medical College of Wisconsin
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 21 Years
Healthy volunteers
No

Inclusion criteria

* Subjects age 0-21 years old with CVS (different phenotypes). Each patient's authorized legal guardian must understand the nature of the study and must provide written informed consent.

Exclusion criteria

* Subjects age \> 22 years old Vomiting is not due to CVS or other related condition

Design outcomes

Primary

MeasureTime frame
Identify novel genes that contribute to the risk of CVS using genomewide association analysis approach.3 years

Secondary

MeasureTime frame
Perform genotype-phenotype correlations between genetic profiles and various phenotypes of CVS (e.g. menstrual, Sato, calendar-tied) and migraine headaches (e.g. with aura, without aura, hemiplegic migraine)3 years

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026